Can B Corp. Enters the Industrial Hemp Business

HICKSVILLE, NY / ACCESSWIRE / May 12, 2021 / Can B Corp. (OTCQB:CANB) ("Can B" or the "Company"), a diversified health and wellness company, is pleased to announce its recent purchases of additional equipment in order to increase production at its industrial hemp facility in Colorado.

In addition to the hemp growing and cultivations already underway in CO and NY under our Botanical Biotech division, the Company is entering the industrial hemp business. Fresh from a farm equipment auction in CO, the Company acquired the basic equipment to grow and harvest industrial hemp. The equipment includes specially modified for hemp combines, grapplers, forage wagons, a semi-tractor/ trailer and a plethora of additional equipment for a full-on grow and harvest, all purchases for dimes on the dollar.

For the uninitiated, Industrial hemp is an incredibly useful plant, one said to have literally tens of thousands of applications. Industrial hemp farmers tend to aim to grow the plants up, not out as is the case with medicinal cannabis - and the taller, the better when grown for fiber. This is because some of the great value of industrial hemp in fiber-based applications is primarily in its stalk. Industrial hemp is also grown at quite high density.

Industrial hemp can grow to 5 meters high, with very long fibers. The stem is comprised of the outer "bark" or bast, sought after for textiles; and the inner material called hurd, which is used for other applications. Another very valuable component of industrial hemp is the seed, which is technically a nut. Industrial hemp is a very hardy plant, able to be hard grown in areas where other crops will fail. It can withstand periods of drought, heat and frost and also be cultivated without pesticides or other chemicals. The plant grows quite quickly, achieving heights of 4 meters in four months. The plant is easy to work with and can be readily transformed into an amazing array of products and used in a multitude of applications, including stock fodder, ropes and cordage, fiberboard, insulation, plastics, hempcrete, clothing and textiles and more.

The Company is currently in discussions with wholesale groups for off-take agreements for our anticipated hemp fiber grows.

Marco Alfonsi, Can B's Chief Executive Officer, commented, "As we see the light at the end of the tunnel from exiting this pandemic era and returning to some resemblance of normalcy, we continue to operate very cautiously with an eye on the future of our business. Our team took advantage of this timing and was able to acquire necessary equipment to expand our industrial hemp operations at an accretive value. We look forward to integrating the new equipment at our facility, as it is a key piece of the puzzle for us to seek additional revenue streams, within our hemp space."

Source: https://finance.yahoo.com/news/b-corp-enters-industrial-hemp-100000894.html

Subscribers,

It's been a while since I alerted you to a pure cannabis play, and it is about time!

So without further ado, meet Can B Corp (CANB).

CANB is a Health & Wellness company providing the highest quality cannabidiol (CBD) products under several popular brands.

According to OTCMarkets.com, the Company has a TINY market cap of just over $7m. Per its latest full year earnings report released one month ago, CANB retired some $2.8m in debt recently, and increased its gross profit by around 10%.

And while its financial results were impacted by COVID-19, the Company's balance sheet remains strong and CANB has solidified and expanded its product line to take advantage of the economy re-opening.

The chart below speaks volumes. And traders are right to be excited.

CANB has super strong long term support at $0.40, just below its current price. A close examination of the 12 month chart below shows multiple bottoms, or multiple "tests" of support, that have failed to break through. This strength is extremely bullish and shows strong buyer demand at this $0.40 level.

The risk vs reward is very favorable. The downside is limited to a few pennies below the long term support line, while the reward is several times this - possibly somewhere between $0.36 - $0.76.



 

Can B Corp. (OTCQB:CANB) is a Health & Wellness company providing the highest quality cannabidiol (CBD) products under the brands of Canbiola, Seven Chakras, NuWellness, Pure Leaf Oil and Duramed. Can B utilizes multi-channel distribution to reach consumers, including medical facilities, doctor offices, retailers, online and direct. Can B is also a license holder of the LifeGuard® Brand in developing a line of consumer products. The Company has launched Super Foods, a line of nutritional supplements. Can B Corp. owns and operates an R&D and production facility in Lacey, WA and Green Grow Farms, a licensed hemp grow and cultivation in New York.

Can B Corp is a health and wellness company. We are dedicated to delivering the highest quality CBD products including tinctures, salves, topical skin care products, and muscle and joint cryo gels.  The products are sold via medical offices, retailers, eCommerce, and direct to consumer.

Our brands include:

• Canbiola, formulated for and distributed via doctors and medical offices.
• Seven Chakras, our spa line including skin care products, massage oils, and bath salts.
• NuWellness, a brand developed for independent pharmacies.
• Pure Leaf Oil, the company's flagship brand developed for retail and eCommerce.

A growing line of additional consumer products is continually being developed at our R&D laboratory located in the Pure Health Products (PHP) production facility in Lacey WA.  Here, we create, develop, test and produce all of the company's CBD products, under the highest industry standards which are also 3rd party independent lab tested with the Certificates of Analysis posted on the company's website.  Additionally, the PHP facility produces under proprietary processes a number of white-label products for other markets.

Additionally, the company has rolled-out a line of Can B SuperFoods powdered drink supplements which are low calorie, and high in fiber, healthy fats, and antioxidants.

Through our Duramed Division, the company offers a line of FDA approved medical devices including an ultrasound delivery device which is proven to alleviate joint and muscle pain in surgery and accident patients, aid in recovery time, and reduce swelling.  These devices are sold and issued via doctors and the medical community and the company believes these devices are contributing to the reduction in opioid use.

In addition, the company owns Green Grow Farms Inc. which holds licenses to grow and cultivate CBD hemp as well as an extraction and processing registration in the State of New York.  Our partner farm agreement allows for selective and targeted hemp grows for our own hemp crops to be processed into isolate for our PHP facility to produce CBD products under multiple brands for the consumer market.  This truly makes us a vertically integrated company, seed to manufacturing to sale.

To learn more about Can B Corp. and our comprehensive line of high quality CBD products, please visit: Canbiola.com and www.CanBCorp.com, follow Can B Corp on Instagram and Facebook, or visit one of the 1,000+ retail outlets that carry Can B Corp. products.

Recent News...

Can B Corp. Announces Full Year 2020 Results

Strong Gross Margin of 84%

Efficiencies and Lower Expenses Lead to a Significant Reduction in Operating Loss

HICKSVILLE, NY / ACCESSWIRE / April 14, 2021 / Can B Corp. (OTCQB:CANB) ("Can B" or the "Company"), a diversified health and wellness company, announced today operating and financial results for the year ended December 31, 2020.

"As it was for many companies, 2020 was a challenging year for us," commented Marco Alfonsi, Can B's Chief Executive Officer. "We took the time to right-size our expenses, focus our energy on higher margin revenue opportunities and improve our positioning for future growth and profits."

Mr. Alfonsi continued, "As an integrated Health & Wellness company providing the highest quality cannabidiol (CBD) products as well as traditional wellness products our business pipeline remains strong. We are optimistic for growth with a return to more normalcy as more and more restrictions ease from the Covid-19 pandemic. We look forward to leveraging our R&D and production facility in Lacey, WA for both our own products and private label for others."

Key Recent Highlights:

• Closed $2.8 million debt financing from an institutional investor, enabling the pay off and elimination of all prior outstanding convertible notes without penalty

• Tripled production with the installation of new high-speed equipment to expand production at its Pure Health Products facility in Lacey, Washington

• Raised a total of $4.0 million in equity with ongoing Reg A offering

• Cash balance of $1.7 million, as of April 2021

Financial Highlights for the Year Ended December 31, 2020 vs. 2019:

• Gross Profit Increased from 74% in 2019 to 84% in 2020 a 10% Increase

• Operating Expenses Decreased $1.8 million a 24% Decrease

• Operating Loss Decreased $1.5 million a 26% Decrease

• Cash balance of $0.5 million

Can B offers several lines of branded CBD products that include tinctures, salves, topicals, skin care products. These brands include Canbiola, developed for the medical community; Seven Chakras, a spa and beauty line; NuWellness for independent Pharmacies, Pure Leaf Oil their flagship consumer brand and Super Foods, a line of nutritional supplements. The Company deploys a multi-channel distribution strategy with products sold via doctors, medical facilities, retailers, online, and direct to consumer.

Key Events Subsequent to the End of 2020:

• Closed on the acquisition of assets and talent from a hemp derivative development and manufacturing group. A newly formed wholly-owned subsidiary, Botanical Biotech LLC ("BB"), will be the new home for Florida-based research & development laboratory and extraction facility for the Company. BB will focus on developing and implementing new pharmacokinetics technology and partnering with global and emerging brands to create innovative products and solutions that are positioned for sustainability and wellness and are culturally driven.

• Signed a definitive agreement to acquire the assets of Imbibe Health Solutions LLC ("Imbibe"), a developer and marketer of CBD and related products. Imbibe has developed several CBD health and wellness products including topical salves, bath soaks, massage oils, and energy and dietary supplements. Can B will be putting Imbibe into one of its current inactive wholly-owned subsidiaries and will be renaming that subsidiary to reflect the products and culture that comes with the Imbibe acquisition.

• Partnered with Dr. Karl Zarse has launched ImmuneX2, a super immune boosting twice a day AM/PM supplement. The two entities have developed a cooperative medical office affiliate program to share in the revenues of ImmuneX2. Can B will be targeting medical professionals and direct-to-consumer sales channels to proactively optimize immune systems.

Financial Results for the Year Ended December 31, 2020:
Revenue for the year ended December 31, 2020 was $1,709,669, a decrease of $595,834 or 26%, compared to $2,305,503 for the year ended December 31, 2019. The decrease was due to the COVID-19 pandemic. Essentially, nationally elective surgeries were curtailed in favor of emergency use of all operating rooms and facilities, which dramatically curtailed the use of our ultrasound device associated with patient recovery. Additionally, distributor and medical office sales of our main-line CBD products such as tinctures and salves, were diminished due to closing and limited access to medical office facilities, again directly tied to the COVID pandemic.

Gross profit for the year ended December 31, 2020 was $1,431,607, resulting in a gross margin of 83.7%, compared to $1,706,919 and 74.0% for the year ended December 31, 2019. Absolute gross profit decreased due to an oversupply of Hemp and CBD biomass in the market. Gross margin increased due favorable product mix to higher margin products and outreach into additional market segments such as wholesale and private label opportunities.

Operating expenses for the year ended December 31, 2020 were $5.8 million, a decrease of $1.8 million or 24%, compared to $7.6 million for the year ended December 31, 2019. This decrease was mainly attributable due to a decrease of $2.8 million in officer's, director's compensation and consulting fees.

Operating loss for the year ended December 31, 2020 was $4.4 million, a decrease of $1.5 million or 26%, compared to $5.9 million for the year ended December 31, 2019.

Net loss for the year ended December 31, 2020 and 2019, was $5.7 million and $5.9 million, respectively, a decrease of $0.2 million, or 3%. The resulting EPS loss for the year ended December 31, 2020 was a ($1.36), as compared to an EPS loss of ($2.20) for the year ended December 31, 2019.

https://finance.yahoo.com/news/b-corp-announces-full-2020-100000887.html

Can B Corp. Acquires Assets from Leading-Edge Hemp Technology Group

Adds Expertise in Pharmacokinetics for the Confluence of Science, Nature, and Culture

HICKSVILLE, NY / ACCESSWIRE / March 18, 2021 / Can B Corp. (OTCQB:CANB) ("Can B" or the "Company"), a diversified health and wellness company, is pleased to announce it has closed on the acquisition of assets and talent from a hemp derivative development and manufacturing group. A newly formed wholly-owned subsidiary, Botanical Biotech LLC ("BB"), will be the new home for Florida-based research & development laboratory and extraction facility for the Company. BB will focus on developing and implementing new pharmacokinetics technology and partnering with global and emerging brands to create innovative products and solutions that are positioned for sustainability and wellness and are culturally driven.

The new subsidiary will be led by President Bradley Lebsock. BB will aim to improve upon what Mother Nature has given us by using cutting-edge science to develop innovations that offer a greater value proposition by optimizing the formulation of plant-based products to improve the bio-availability of bio- active compounds and ensure long-term stability to ensure the consumer has a consistent experience. There are several strategies that can be used to enhance the liberation, solubilization, and absorption of bio-active compounds. BB's extensive experience utilizing these pharmaceutical homogenization techniques allowing us to manipulate molecules and offer scalable cost-effective formulations paired with the ability to articulate the unique value propositions of a formula through our in-house marketing and communications team.

B&B's team are at the forefront of hemp isolate extraction into CBG, CBN, and other cannabinoids found in the hemp plant. According to a February 2020 Healthline Media report, "CBD and CBG are both non-intoxicating cannabinoids, meaning they won't make you high, and both interact with the same receptors in the body, according to a 2018 study Trusted Source, and appear to have anti-inflammatory effects". The article goes on to name a plethora of possible additional benefits of the CBG and CBN cannabinoids.

Marco Alfonsi, Can B's Chief Executive Officer, commented, "We are thrilled to bring Brad's team under our umbrella and leverage their scientific approach to our current and future developed products. Their product development and science-based technology and innovations will benefit our proprietary brands and Pure Health Products production facility in WA. We look forward to working more closely with Brad and his team at Can B Corp."

https://finance.yahoo.com/news/b-corp-acquires-assets-leading-100000578.html



All the best.

SmallCapMomo.com

picks@smallcapmomo.com

Remember our key trading rules when trading. Capital preservation is key. Keep your stops tight, and if things don't go your way, cut your losses and look for another opportunity.